Market Cap 9.31M
Revenue (ttm) 9.36M
Net Income (ttm) -9.04M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -96.58%
Debt to Equity Ratio 0.07
Volume 188,400
Avg Vol 11,801,870
Day's Range N/A - N/A
Shares Out 18.25M
Stochastic %K 23%
Beta 3.45
Analysts Hold
Price Target $6.00

Latest News on BIAF

bioAffinity Technologies Set for Continued Expansion in 2025

Dec 12, 2024, 8:00 AM EST - 4 months ago

bioAffinity Technologies Set for Continued Expansion in 2025


bioAffinity Technologies News Update

May 2, 2024, 8:00 AM EDT - 1 year ago

bioAffinity Technologies News Update


bioAffinity Technologies In The News

Jan 30, 2024, 8:00 AM EST - 1 year ago

bioAffinity Technologies In The News


bioAffinity Technologies In the News

Jan 8, 2024, 8:00 AM EST - 1 year ago

bioAffinity Technologies In the News